Companies / Japan
Wyeth To File New Drugs In Japan
July 2006 | Product LaunchUS pharmaceuticals and healthcare major Wyeth is to launch more drugs in Japan this year, with regulatory filings expected for six new products. Sales efforts on the company's locally leading product, the rheumatoid arthritis drug Embrel (etanercept) are also to be stepped
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
